The role of colonizing and infecting pathogens (wound bioburden) on diabetic foot ulcer (DFU) outcomes remains unclear. Our group has shown that the totality of microorganisms in DFUs measured using high throughput 16S ribosomal RNA (rRNA) gene sequencing, is directly related to: ulcer duration, ulcer depth, and poor glycemic control. However, changes in bioburden over time provided only limited insights into the role of these changes on DFU outcomes. Nonetheless, bioburden may be influencing DFU outcomes, but the specific dimensions of importance may not be discernable using 16S rRNA profiling. Major limitations of this molecular technique include the fact that it does not disclose functional potential of the microbiota and resolution to species or strain level is often impossible. To circumvent these limitations, we will employ whole genome shotgun (WGS) metagenomic sequencing and analysis, a powerful lens for deciphering the functional potential of microbial communities. Our overarching hypothesis is that specific dimensions of the dynamic DFU microbiome are predictive of outcome. Additionally, we hypothesize that different treatment regimens have different effects on the DFU microbiome. We have assembled a multi-disciplinary team of experts to execute the aims of this proposal, with basic science expertise in wound microbiome and metagenomics and clinical and research expertise in DFUs and infection. To test our hypothesis, we will complete the following aims:
Aim 1 : Determine if pathogenic species/strains and overall microbial diversity of the DFU metagenome are associated with specific DFU outcomes. We will characterize the changes in metagenomes over time for 107 subjects with DFUs recruited from our previous studies, from whom specimens were collected every 2 weeks from presentation to final outcome. We will determine if 1) the presence of specific species or strains of pathogens (e.g. beta-hemolytic Streptococcus); and 2) low microbial diversity are directly associated with lower rates of healing or infection-related complications (i.e., ulcer deterioration, osteomyelitis or amputation).
Aim 2 : Determine if pathogenicity genes in the DFU metagenome are associated with specific DFU outcomes. We will examine the presence and relative abundance of genes conferring 1) biofilm-formation potential, 2) antibiotic resistance and, 3) virulence factors, to determine if they are association with lower rates of healing and infection-related complications.
Aim 3 : Determine the effects of aggressive sharp debridement and antibiotic treatment on the DFU metagenome. This is the first longitudinal study of the role of the DFU microbiome on DFU outcomes using WGS metagenomic sequencing as well as the first to examine the impact of two commonly employed antimicrobial interventions on the DFU metagenome.

Public Health Relevance

Chronic non-healing foot wounds develop in as many as 25% of persons with diabetes, and are often colonized or infected with microbes, though the role of microbes in healing and complications is unclear. This application aims to test the hypothesis that specific dimensions of the dynamic microbiota colonizing diabetic foot ulcers (DFUs) are predictive of outcome. We will utilize state-of-the-science metagenomic techniques and analyses to obtain a better understanding of how the DFU microbiome changes throughout development and resolution of infection and wound healing, allowing us to determine if the microbiome has predictive value for DFU outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Nursing Research (NINR)
Type
Research Project (R01)
Project #
5R01NR015639-03
Application #
9223575
Study Section
Special Emphasis Panel (ZNR1-REV-M (18))
Program Officer
Tully, Lois
Project Start
2015-05-01
Project End
2018-02-28
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
3
Fiscal Year
2017
Total Cost
$423,314
Indirect Cost
$140,621
Name
University of Pennsylvania
Department
Dermatology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Zheng, Qi; Bartow-McKenney, Casey; Meisel, Jacquelyn S et al. (2018) HmmUFOtu: An HMM and phylogenetic placement based ultra-fast taxonomic assignment and OTU picking tool for microbiome amplicon sequencing studies. Genome Biol 19:82
SanMiguel, Adam J; Meisel, Jacquelyn S; Horwinski, Joseph et al. (2018) Antiseptic Agents Elicit Short-Term, Personalized, and Body Site-Specific Shifts in Resident Skin Bacterial Communities. J Invest Dermatol 138:2234-2243
Meisel, Jacquelyn S; Sfyroera, Georgia; Bartow-McKenney, Casey et al. (2018) Commensal microbiota modulate gene expression in the skin. Microbiome 6:20
Bartow-McKenney, Casey; Hannigan, Geoffrey D; Horwinski, Joseph et al. (2018) The microbiota of traumatic, open fracture wounds is associated with mechanism of injury. Wound Repair Regen 26:127-135
Loesche, Michael; Gardner, Sue E; Kalan, Lindsay et al. (2017) Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing. J Invest Dermatol 137:237-244
Kalan, Lindsay; Loesche, Michael; Hodkinson, Brendan P et al. (2016) Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing. MBio 7:
Meisel, Jacquelyn S; Hannigan, Geoffrey D; Tyldsley, Amanda S et al. (2016) Skin Microbiome Surveys Are Strongly Influenced by Experimental Design. J Invest Dermatol 136:947-956
Kalan, Lindsay; Gardner, Sue E; Grice, Elizabeth A (2016) Reply to ""Understanding the Role of Fungi in Chronic Wounds"". MBio 7: